These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 15021998)
1. [Sudden cardiac death (SCD) and guidelines for SCD]. Andresen D Z Kardiol; 2004; 93 Suppl 1():I4-6. PubMed ID: 15021998 [TBL] [Abstract][Full Text] [Related]
2. [Recommendations for secondary prevention after myocardial infarction]. Arntz HR Z Kardiol; 2004; 93 Suppl 1():I23-5. PubMed ID: 15022004 [TBL] [Abstract][Full Text] [Related]
3. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction. Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S; Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497 [TBL] [Abstract][Full Text] [Related]
5. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Albert CM; Oh K; Whang W; Manson JE; Chae CU; Stampfer MJ; Willett WC; Hu FB Circulation; 2005 Nov; 112(21):3232-8. PubMed ID: 16301356 [TBL] [Abstract][Full Text] [Related]
6. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838 [TBL] [Abstract][Full Text] [Related]
7. Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure. Anand K; Mooss AN; Mohiuddin SM J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):15-9. PubMed ID: 17083069 [TBL] [Abstract][Full Text] [Related]
8. Traditional heart failure medications and sudden cardiac death prevention: a review. Al Chekakie MO J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):412-26. PubMed ID: 23766358 [TBL] [Abstract][Full Text] [Related]
9. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648 [TBL] [Abstract][Full Text] [Related]
10. Circadian variations in cardiac disease: clinical implications. Current strategies for preventing MI, dysrhythmias, sudden death. Lundberg GP; Liebson PR; Calvin JE J Crit Illn; 1995 Oct; 10(10):693-6, 699-700, 705-7. PubMed ID: 10155744 [TBL] [Abstract][Full Text] [Related]
11. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric basic life support. American Heart Association Pediatrics; 2006 May; 117(5):e989-1004. PubMed ID: 16651298 [TBL] [Abstract][Full Text] [Related]
12. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies. Siddiqui A; Kowey PR Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017 [TBL] [Abstract][Full Text] [Related]
13. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201 [TBL] [Abstract][Full Text] [Related]
15. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605 [TBL] [Abstract][Full Text] [Related]